Spherical Cancer Models in Tumor Biology

Neoplasia (United States)

Volumn 17, Issue 1, 2015, Pages 1-15

  Weiswald, Louis Bastien ^a,b,c,d   Bellet, Dominique ^c,d   Dangles Marie, Virginie ^c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c INSTITUT CURIE   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

BIOLOGY; CANCER CELL CULTURE; CANCER CELL LINE; CANCER CLASSIFICATION; CANCER MODEL; CANCER RESEARCH; CANCER STEM CELL; CARCINOGENICITY; CHEMOSENSITIVITY; CONFORMATION; DISSOCIATION; DRUG RESISTANCE; HUMAN; IN VITRO STUDY; MALIGNANT NEOPLASM; METASTASIS; MULTICELLULAR SPHEROID; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; REVIEW; STEM CELL EXPANSION; TUMOR INVASION; TUMOR SPHEROID; ANIMAL; DRUG EFFECTS; DRUG SCREENING; METABOLISM; NEOPLASMS; PATHOLOGY; RADIATION DOSE; RADIATION RESPONSE; TISSUE CULTURE TECHNIQUE; TUMOR CELL CULTURE;

ANIMALS; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; IN VITRO TECHNIQUES; NEOPLASMS; NEOPLASTIC STEM CELLS; RADIATION TOLERANCE; SPHEROIDS, CELLULAR; TISSUE CULTURE TECHNIQUES; TUMOR CELLS, CULTURED;

EID: 84964693878     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1016/j.neo.2014.12.004     Document Type: Review

References (178)

1. Durand, R.E., Raleigh, J.A., Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res 58 (1998), 3547–3550.
2. Pampaloni, F., Reynaud, E.G., Stelzer, E.H., The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8 (2007), 839–845.
3. Baker, B.M., Chen, C.S., Deconstructing the third dimension: how 3D culture microenvironments alter cellular cues. J Cell Sci 125 (2012), 3015–3024.
4. Sutherland, R.M., Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240 (1988), 177–184.
5. Vaira, V., Fedele, G., Pyne, S., Fasoli, E., Zadra, G., Bailey, D., Snyder, E., Faversani, A., Coggi, G., Flavin, R., et al. Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. Proc Natl Acad Sci U S A 107 (2010), 8352–8356.
6. Kyle, A.H., Huxham, L.A., Chiam, A.S., Sim, D.H., Minchinton, A.I., Direct assessment of drug penetration into tissue using a novel application of three-dimensional cell culture. Cancer Res 64 (2004), 6304–6309.
7. Fischbach, C., Chen, R., Matsumoto, T., Schmelzle, T., Brugge, J.S., Polverini, P.J., Mooney, D.J., Engineering tumors with 3D scaffolds. Nat Methods 4 (2007), 855–860.
8. Barrila, J., Radtke, A.L., Crabbe, A., Sarker, S.F., Herbst-Kralovetz, M.M., Ott, C.M., Nickerson, C.A., Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions. Nat Rev Microbiol 8 (2010), 791–801.
9. Thoma, C.R., Zimmermann, M., Agarkova, I., Kelm, J.M., Krek, W., 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev 69–70 (2014), 29–41.
10. Junttila, M.R., de Sauvage, F.J., Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501 (2013), 346–354.
11. Inch, W.R., McCredie, J.A., Sutherland, R.M., Growth of nodular carcinomas in rodents compared with multi-cell spheroids in tissue culture. Growth 34 (1970), 271–282.
12. Sutherland, R.M., McCredie, J.A., Inch, W.R., Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. J Natl Cancer Inst 46 (1971), 113–120.
13. Bjerkvig, R., Tonnesen, A., Laerum, O.D., Backlund, E.O., Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 72 (1990), 463–475.
14. Kaaijk, P., Troost, D., Das, P.K., Leenstra, S., Bosch, D.A., Long-term culture of organotypic multicellular glioma spheroids: a good culture model for studying gliomas. Neuropathol Appl Neurobiol 21 (1995), 386–391.
15. Weiswald, L.B., Richon, S., Validire, P., Briffod, M., Lai-Kuen, R., Cordelieres, F.P., Bertrand, F., Dargere, D., Massonnet, G., Marangoni, E., et al. Newly characterised ex vivo colospheres as a three-dimensional colon cancer cell model of tumour aggressiveness. Br J Cancer 101 (2009), 473–482.
16. Kondo, J., Endo, H., Okuyama, H., Ishikawa, O., Iishi, H., Tsujii, M., Ohue, M., Inoue, M., Retaining cell–cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer. Proc Natl Acad Sci U S A 108 (2011), 6235–6240.
17. McBain, J.A., Weese, J.L., Meisner, L.F., Wolberg, W.H., Willson, J.K., Establishment and characterization of human colorectal cancer cell lines. Cancer Res 44 (1984), 5813–5821.
18. Park, J.G., Oie, H.K., Sugarbaker, P.H., Henslee, J.G., Chen, T.R., Johnson, B.E., Gazdar, A., Characteristics of cell lines established from human colorectal carcinoma. Cancer Res 47 (1987), 6710–6718.
19. Oh, J.H., Ku, J.L., Yoon, K.A., Kwon, H.J., Kim, W.H., Park, H.S., Yeo, K.S., Song, S.Y., Chung, J.K., Park, J.G., Establishment and characterization of 12 human colorectal-carcinoma cell lines. Int J Cancer 81 (1999), 902–910.
20. Weiswald, L.B., Richon, S., Massonnet, G., Guinebretiere, J.M., Vacher, S., Laurendeau, I., Cottu, P., Marangoni, E., Nemati, F., Validire, P., et al. A short-term colorectal cancer sphere culture as a relevant tool for human cancer biology investigation. Br J Cancer 108 (2013), 1720–1731.
21. Young, S.R., Saar, M., Santos, J., Nguyen, H.M., Vessella, R.L., Peehl, D.M., Establishment and serial passage of cell cultures derived from LuCaP xenografts. Prostate 73 (2013), 1251–1262.
22. Sutherland, R.M., Inch, W.R., McCredie, J.A., Kruuv, J., A multi-component radiation survival curve using an in vitro tumour model. Int J Radiat Biol Relat Stud Phys Chem Med 18 (1970), 491–495.
23. Sato, T., Vries, R.G., Snippert, H.J., van de Wetering, M., Barker, N., Stange, D.E., van Es, J.H., Abo, A., Kujala, P., Peters, P.J., et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459 (2009), 262–265.
24. Lazaro, C.A., Croager, E.J., Mitchell, C., Campbell, J.S., Yu, C., Foraker, J., Rhim, J.A., Yeoh, G.C., Fausto, N., Establishment, characterization, and long-term maintenance of cultures of human fetal hepatocytes. Hepatology 38 (2003), 1095–1106.
25. Kuperwasser, C., Chavarria, T., Wu, M., Magrane, G., Gray, J.W., Carey, L., Richardson, A., Weinberg, R.A., Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A 101 (2004), 4966–4971.
26. Whitehead, R.H., Jones, J.K., Gabriel, A., Lukies, R.E., A new colon carcinoma cell line (LIM1863) that grows as organoids with spontaneous differentiation into crypt-like structures in vitro. Cancer Res 47 (1987), 2683–2689.
27. Lebret, S.C., Newgreen, D.F., Thompson, E.W., Ackland, M.L., Induction of epithelial to mesenchymal transition in PMC42-LA human breast carcinoma cells by carcinoma-associated fibroblast secreted factors. Breast Cancer Res, 9, 2007, R19.
28. Sung, S.Y., Hsieh, C.L., Law, A., Zhau, H.E., Pathak, S., Multani, A.S., Lim, S., Coleman, I.M., Wu, L.C., Figg, W.D., et al. Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis. Cancer Res 68 (2008), 9996–10003.
29. Mayer, B., Klement, G., Kaneko, M., Man, S., Jothy, S., Rak, J., Kerbel, R.S., Multicellular gastric cancer spheroids recapitulate growth pattern and differentiation phenotype of human gastric carcinomas. Gastroenterology 121 (2001), 839–852.
30. Gupta, P.B., Onder, T.T., Jiang, G., Tao, K., Kuperwasser, C., Weinberg, R.A., Lander, E.S., Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138 (2009), 645–659.
31. Lin, L., Liu, A., Peng, Z., Lin, H.J., Li, P.K., Li, C., Lin, J., STAT3 is necessary for proliferation and survival in colon cancer-initiating cells. Cancer Res 71 (2011), 7226–7237.
32. Charafe-Jauffret, E., Monville, F., Ginestier, C., Dontu, G., Birnbaum, D., Wicha, M.S., Cancer stem cells in breast: current opinion and future challenges. Pathobiology 75 (2008), 75–84.
33. Fang, D.D., Kim, Y.J., Lee, C.N., Aggarwal, S., McKinnon, K., Mesmer, D., Norton, J., Birse, C.E., He, T., Ruben, S.M., et al. Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery. Br J Cancer 102 (2010), 1265–1275.
34. Oskarsson, T., Acharyya, S., Zhang, X.H., Vanharanta, S., Tavazoie, S.F., Morris, P.G., Downey, R.J., Manova-Todorova, K., Brogi, E., Massague, J., Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med 17 (2011), 867–874.
35. Reynolds, B.A., Weiss, S., Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255 (1992), 1707–1710.
36. Singh, S.K., Clarke, I.D., Terasaki, M., Bonn, V.E., Hawkins, C., Squire, J., Dirks, P.B., Identification of a cancer stem cell in human brain tumors. Cancer Res 63 (2003), 5821–5828.
37. Dontu, G., Abdallah, W.M., Foley, J.M., Jackson, K.W., Clarke, M.F., Kawamura, M.J., Wicha, M.S., In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17 (2003), 1253–1270.
38. Ponti, D., Costa, A., Zaffaroni, N., Pratesi, G., Petrangolini, G., Coradini, D., Pilotti, S., Pierotti, M.A., Daidone, M.G., Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65 (2005), 5506–5511.
39. Ricci-Vitiani, L., Lombardi, D.G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., De Maria, R., Identification and expansion of human colon-cancer-initiating cells. Nature 445 (2007), 111–115.
40. Todaro, M., Alea, M.P., Di Stefano, A.B., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Russo, A., Gulotta, G., Medema, J.P., et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1 (2007), 389–402.
41. Shmelkov, S.V., Butler, J.M., Hooper, A.T., Hormigo, A., Kushner, J., Milde, T., St Clair, R., Baljevic, M., White, I., Jin, D.K., et al. CD133 expression is not restricted to stem cells, and both CD133 + and CD133 − metastatic colon cancer cells initiate tumors. J Clin Invest 118 (2008), 2111–2120.
42. Dallas, N.A., Xia, L., Fan, F., Gray, M.J., Gaur, P., van Buren, G. II, Samuel, S., Kim, M.P., Lim, S.J., Ellis, L.M., Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res 69 (2009), 1951–1957.
43. Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., Kunz-Schughart, L.A., Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol 148 (2010), 3–15.
44. Cammareri, P., Scopelliti, A., Todaro, M., Eterno, V., Francescangeli, F., Moyer, M.P., Agrusa, A., Dieli, F., Zeuner, A., Stassi, G., Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells. Cancer Res 70 (2010), 4655–4665.
45. Thorsen, F., Enger, P.O., Wang, J., Bjerkvig, R., Pedersen, P.H., Human glioblastoma biopsy spheroids xenografted into the nude rat brain show growth inhibition after stereotactic radiosurgery. J Neurooncol 82 (2007), 1–10.
46. Kim, K.U., Wilson, S.M., Abayasiriwardana, K.S., Collins, R., Fjellbirkeland, L., Xu, Z., Jablons, D.M., Nishimura, S.L., Broaddus, V.C., A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance. Am J Respir Cell Mol Biol 33 (2005), 541–548.
47. Weroha, S.J., Becker, M.A., Enderica-Gonzalez, S., Harrington, S.C., Oberg, A.L., Maurer, M.J., Perkins, S.E., Alhilli, M., Butler, K.A., McKinstry, S., et al. Tumorgrafts as in vivo surrogates for women with ovarian cancer. Clin Cancer Res 20 (2014), 1288–1297.
48. Burleson, K.M., Casey, R.C., Skubitz, K.M., Pambuccian, S.E., Oegema, T.R. Jr., Skubitz, A.P., Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol Oncol 93 (2004), 170–181.
49. Friedrich, J., Seidel, C., Ebner, R., Kunz-Schughart, L.A., Spheroid-based drug screen: considerations and practical approach. Nat Protoc 4 (2009), 309–324.
50. Friedrich, J., Ebner, R., Kunz-Schughart, L.A., Experimental anti-tumor therapy in 3-D: spheroids—old hat or new challenge?. Int J Radiat Biol 83 (2007), 849–871.
51. Yuhas, J.M., Li, A.P., Martinez, A.O., Ladman, A.J., A simplified method for production and growth of multicellular tumor spheroids. Cancer Res 37 (1977), 3639–3643.
52. Dangles-Marie, V., Pocard, M., Richon, S., Weiswald, L.B., Assayag, F., Saulnier, P., Judde, J.G., Janneau, J.L., Auger, N., Validire, P., et al. Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. Cancer Res 67 (2007), 398–407.
53. Dangles, V., Femenia, F., Laine, V., Berthelemy, M., Le Rhun, D., Poupon, M.F., Levy, D., Schwartz-Cornil, I., Two- and three-dimensional cell structures govern epidermal growth factor survival function in human bladder carcinoma cell lines. Cancer Res 57 (1997), 3360–3364.
54. Vinci, M., Gowan, S., Boxall, F., Patterson, L., Zimmermann, M., Court, W., Lomas, C., Mendiola, M., Hardisson, D., Eccles, S.A., Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation. BMC Biol, 10, 2012, 29.
55. Kelm, J.M., Timmins, N.E., Brown, C.J., Fussenegger, M., Nielsen, L.K., Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng 83 (2003), 173–180.
56. Sakai, S., Inamoto, K., Liu, Y., Tanaka, S., Arii, S., Taya, M., Multicellular tumor spheroid formation in duplex microcapsules for analysis of chemosensitivity. Cancer Sci 103 (2012), 549–554.
57. Zhang, X., Wang, W., Yu, W., Xie, Y., Zhang, Y., Ma, X., Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing. Biotechnol Prog 21 (2005), 1289–1296.
58. Sakai, S., Ito, S., Kawakami, K., Calcium alginate microcapsules with spherical liquid cores templated by gelatin microparticles for mass production of multicellular spheroids. Acta Biomater 6 (2010), 3132–3137.
59. Alessandri, K., Sarangi, B.R., Gurchenkov, V.V., Sinha, B., Kießling, T.R., Fetler, L., Rico, F., Scheuring, S., Lamaze, C., Simon, A., et al. Cellular capsules as a tool for multicellular spheroid production and for investigating the mechanics of tumor progression in vitro. Proc Natl Acad Sci U S A 110:37 (2013), 14843–14848.
60. Longati, P., Jia, X., Eimer, J., Wagman, A., Witt, M.R., Rehnmark, S., Verbeke, C., Toftgard, R., Lohr, M., Heuchel, R.L., 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer, 13, 2013, 95.
61. Dangles, V., Validire, P., Wertheimer, M., Richon, S., Bovin, C., Zeliszewski, D., Vallancien, G., Bellet, D., Impact of human bladder cancer cell architecture on autologous T-lymphocyte activation. Int J Cancer 98 (2002), 51–56.
62. Dangles-Marie, V., Richon, S., El-Behi, M., Echchakir, H., Dorothee, G., Thiery, J., Validire, P., Vergnon, I., Menez, J., Ladjimi, M., et al. A three-dimensional tumor cell defect in activating autologous CTLs is associated with inefficient antigen presentation correlated with heat shock protein-70 down-regulation. Cancer Res 63 (2003), 3682–3687.
63. Spoettl, T., Hausmann, M., Herlyn, M., Gunckel, M., Dirmeier, A., Falk, W., Herfarth, H., Schoelmerich, J., Rogler, G., Monocyte chemoattractant protein-1 (MCP-1) inhibits the intestinal-like differentiation of monocytes. Clin Exp Immunol 145 (2006), 190–199.
64. Timmins, N.E., Dietmair, S., Nielsen, L.K., Hanging-drop multicellular spheroids as a model of tumour angiogenesis. Angiogenesis 7 (2004), 97–103.
65. Oudar, O., Spheroids: relation between tumour and endothelial cells. Crit Rev Oncol Hematol 36 (2000), 99–106.
66. Uchida, N., Buck, D.W., He, D., Reitsma, M.J., Masek, M., Phan, T.V., Tsukamoto, A.S., Gage, F.H., Weissman, I.L., Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 97 (2000), 14720–14725.
67. Eramo, A., Lotti, F., Sette, G., Pilozzi, E., Biffoni, M., Di Virgilio, A., Conticello, C., Ruco, L., Peschle, C., De Maria, R., Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15 (2008), 504–514.
68. Collins, A.T., Berry, P.A., Hyde, C., Stower, M.J., Maitland, N.J., Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65 (2005), 10946–10951.
69. Li, C., Heidt, D.G., Dalerba, P., Burant, C.F., Zhang, L., Adsay, V., Wicha, M., Clarke, M.F., Simeone, D.M., Identification of pancreatic cancer stem cells. Cancer Res 67 (2007), 1030–1037.
70. Zhang, S., Balch, C., Chan, M.W., Lai, H.C., Matei, D., Schilder, J.M., Yan, P.S., Huang, T.H., Nephew, K.P., Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 68 (2008), 4311–4320.
71. Yu, M., Bardia, A., Aceto, N., Bersani, F., Madden, M.W., Donaldson, M.C., Desai, R., Zhu, H., Comaills, V., Zheng, Z., et al. Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility. Science 345 (2014), 216–220.
72. Venkataraman, G., Sasisekharan, V., Herr, A.B., Ornitz, D.M., Waksman, G., Cooney, C.L., Langer, R., Sasisekharan, R., Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation. Proc Natl Acad Sci U S A 93 (1996), 845–850.
73. Rappa, G., Mercapide, J., Anzanello, F., Prasmickaite, L., Xi, Y., Ju, J., Fodstad, O., Lorico, A., Growth of cancer cell lines under stem cell-like conditions has the potential to unveil therapeutic targets. Exp Cell Res 314 (2008), 2110–2122.
74. Sato, T., Stange, D.E., Ferrante, M., Vries, R.G., Van Es, J.H., Van den Brink, S., Van Houdt, W.J., Pronk, A., Van Gorp, J., Siersema, P.D., et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 141 (2011), 1762–1772.
75. Visvader, J.E., Lindeman, G.J., Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8 (2008), 755–768.
76. Pastrana, E., Silva-Vargas, V., Doetsch, F., Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 8 (2011), 486–498.
77. Singec, I., Knoth, R., Meyer, R.P., Maciaczyk, J., Volk, B., Nikkhah, G., Frotscher, M., Snyder, E.Y., Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Nat Methods 3 (2006), 801–806.
78. Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., Brooks, M., Reinhard, F., Zhang, C.C., Shipitsin, M., et al. The epithelial–mesenchymal transition generates cells with properties of stem cells. Cell 133 (2008), 704–715.
79. Alpaugh, M.L., Tomlinson, J.S., Shao, Z.M., Barsky, S.H., A novel human xenograft model of inflammatory breast cancer. Cancer Res 59 (1999), 5079–5084.
80. Morales, J., Alpaugh, M.L., Gain in cellular organization of inflammatory breast cancer: a 3D in vitro model that mimics the in vivo metastasis. BMC Cancer, 9, 2009, 462.
81. Bolenz, C., Ikinger, E.M., Strobel, P., Trojan, L., Steidler, A., Fernandez, M.I., Honeck, P., Gabriel, U., Weiss, C., Grobholz, R., et al. Topical chemotherapy in human urothelial carcinoma explants: a novel translational tool for preclinical evaluation of experimental intravesical therapies. Eur Urol 56 (2009), 504–511.
82. Muthuswamy, R., Berk, E., Fallert Junecko, B., Zeh, H.J., Zureikat, A.H., Normolle, D., Luong, T.M., Reinhart, T.A., Bartlett, D.L., Kalinski, P., NF-kappaB hyper-activation in tumor tissues allows tumor-selective reprogramming of chemokine microenvironment to enhance the recruitment of cytolytic T effector cells. Cancer Res 72:15 (2012), 3735–3743.
83. Bjerkvig, R., Hostmark, J., Pedersen, P., Laerum, O., Tumor Spheroids from Biopsy Specimens. Bjerkvig, (eds.) Spheroid Culture in Cancer Research, 1992, CRC Press, Boca Raton, FL, 41–56.
84. Rajcevic, U., Knol, J.C., Piersma, S., Bougnaud, S., Fack, F., Sundlisaeter, E., Sondenaa, K., Myklebust, R., Pham, T.V., Niclou, S.P., et al. Colorectal cancer derived organotypic spheroids maintain essential tissue characteristics but adapt their metabolism in culture. Proteome Sci, 12, 2014, 39.
85. Sundlisaeter, E., Wang, J., Sakariassen, P.O., Marie, M., Mathisen, J.R., Karlsen, B.O., Prestegarden, L., Skaftnesmo, K.O., Bjerkvig, R., Enger, P.O., Primary glioma spheroids maintain tumourogenicity and essential phenotypic traits after cryopreservation. Neuropathol Appl Neurobiol 32 (2006), 419–427.
86. Mahesparan, R., Tysnes, B.B., Read, T.A., Enger, P.O., Bjerkvig, R., Lund-Johansen, M., Extracellular matrix-induced cell migration from glioblastoma biopsy specimens in vitro. Acta Neuropathol 97 (1999), 231–239.
87. Paulus, W., Huettner, C., Tonn, J.C., Collagens, integrins and the mesenchymal drift in glioblastomas: a comparison of biopsy specimens, spheroid and early monolayer cultures. Int J Cancer 58 (1994), 841–846.
88. Tonn, J.C., Ott, M.M., Meixensberger, J., Paulus, W., Roosen, K., Progesterone receptors are detectable in tumor fragment spheroids of meningiomas in vitro. Anticancer Res 14 (1994), 2453–2456.
89. Heimdal, J., Aarstad, H.J., Olofsson, J., Monocytes secrete interleukin-6 when co-cultured in vitro with benign or malignant autologous fragment spheroids from squamous cell carcinoma patients. Scand J Immunol 51 (2000), 271–278.
90. Fjellbirkeland, L., Bjerkvig, R., Laerum, O.D., Tumour fragment spheroids from human non-small-cell lung cancer maintained in organ culture. Virchows Arch 426 (1995), 169–178.
91. Burgues, J.P., Gomez, L., Pontones, J.L., Vera, C.D., Jimenez-Cruz, J.F., Ozonas, M., A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids. Eur Urol 51 (2007), 962–969 [discussion 969–970].
92. Shield, K., Ackland, M.L., Ahmed, N., Rice, G.E., Multicellular spheroids in ovarian cancer metastases: biology and pathology. Gynecol Oncol 113 (2009), 143–148.
93. Santini, M.T., Rainaldi, G., Three-dimensional spheroid model in tumor biology. Pathobiology 67 (1999), 148–157.
94. Haji-Karim, M., Carlsson, J., Proliferation and viability in cellular spheroids of human origin. Cancer Res 38 (1978), 1457–1464.
95. Lawlor, E.R., Scheel, C., Irving, J., Sorensen, P.H., Anchorage-independent multi-cellular spheroids as an in vitro model of growth signaling in Ewing tumors. Oncogene 21 (2002), 307–318.
96. Kang, H.G., Jenabi, J.M., Zhang, J., Keshelava, N., Shimada, H., May, W.A., Ng, T., Reynolds, C.P., Triche, T.J., Sorensen, P.H., E-cadherin cell–cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase. Cancer Res 67 (2007), 3094–3105.
97. Mueller, S., Cadenas, E., Schonthal, A.H., p21WAF1 regulates anchorage-independent growth of HCT116 colon carcinoma cells via E-cadherin expression. Cancer Res 60 (2000), 156–163.
98. Steadman, K., Stein, W.D., Litman, T., Yang, S.X., Abu-Asab, M., Dutcher, S.K., Bates, S., PolyHEMA spheroids are an inadequate model for the drug resistance of the intractable solid tumors. Cell Cycle 7 (2008), 818–829.
99. Xiang, X., Phung, Y., Feng, M., Nagashima, K., Zhang, J., Broaddus, V.C., Hassan, R., Fitzgerald, D., Ho, M., The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy. PLoS One, 6, 2011, e14640.
100. Dangles, V., Lazar, V., Validire, P., Richon, S., Wertheimer, M., Laville, V., Janneau, J.L., Barrois, M., Bovin, C., Poynard, T., et al. Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns. Br J Cancer 86 (2002), 1283–1289.
101. Waleh, N.S., Gallo, J., Grant, T.D., Murphy, B.J., Kramer, R.H., Sutherland, R.M., Selective down-regulation of integrin receptors in spheroids of squamous cell carcinoma. Cancer Res 54 (1994), 838–843.
102. Lin, R.Z., Chou, L.F., Chien, C.C., Chang, H.Y., Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and beta1-integrin. Cell Tissue Res 324 (2006), 411–422.
103. Mueller-Klieser, W., Three-dimensional cell cultures: from molecular mechanisms to clinical applications. Am J Physiol 273 (1997), C1109–C1123.
104. Nederman, T., Norling, B., Glimelius, B., Carlsson, J., Brunk, U., Demonstration of an extracellular matrix in multicellular tumor spheroids. Cancer Res 44 (1984), 3090–3097.
105. Dolznig, H., Rupp, C., Puri, C., Haslinger, C., Schweifer, N., Wieser, E., Kerjaschki, D., Garin-Chesa, P., Modeling colon adenocarcinomas in vitro a 3D co-culture system induces cancer-relevant pathways upon tumor cell and stromal fibroblast interaction. Am J Pathol 179 (2011), 487–501.
106. Sutherland, R.M., Sordat, B., Bamat, J., Gabbert, H., Bourrat, B., Mueller-Klieser, W., Oxygenation and differentiation in multicellular spheroids of human colon carcinoma. Cancer Res 46 (1986), 5320–5329.
107. Myungjin Lee, J., Mhawech-Fauceglia, P., Lee, N., Cristina Parsanian, L., Gail Lin, Y., Andrew Gayther, S., Lawrenson, K., A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro. Lab Invest 93 (2013), 528–542.
108. Valent, P., Bonnet, D., De Maria, R., Lapidot, T., Copland, M., Melo, J.V., Chomienne, C., Ishikawa, F., Schuringa, J.J., Stassi, G., et al. Cancer stem cell definitions and terminology: the devil is in the details. Nat Rev Cancer 12 (2012), 767–775.
109. Dieter, S.M., Ball, C.R., Hoffmann, C.M., Nowrouzi, A., Herbst, F., Zavidij, O., Abel, U., Arens, A., Weichert, W., Brand, K., et al. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell 9 (2011), 357–365.
110. Vermeulen, L., Todaro, M., de Sousa, Mello F., Sprick, M.R., Kemper, K., Perez Alea, M., Richel, D.J., Stassi, G., Medema, J.P., Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 105 (2008), 13427–13432.
111. Prasetyanti, P.R., Zimberlin, C., De Sousa, E.M.F., Medema, J.P., Isolation and propagation of colon cancer stem cells. Methods Mol Biol 1035 (2013), 247–259.
112. Smart, C.E., Morrison, B.J., Saunus, J.M., Vargas, A.C., Keith, P., Reid, L., Wockner, L., Amiri, M.A., Sarkar, D., Simpson, P.T., et al. In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity. PLoS One, 8, 2013, e64388.
113. Chen, R., Nishimura, M.C., Bumbaca, S.M., Kharbanda, S., Forrest, W.F., Kasman, I.M., Greve, J.M., Soriano, R.H., Gilmour, L.L., Rivers, C.S., et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. Cancer Cell 17 (2010), 362–375.
114. Vermeulen, L., De Sousa, E.M.F., van der Heijden, M., Cameron, K., de Jong, J.H., Borovski, T., Tuynman, J.B., Todaro, M., Merz, C., Rodermond, H., et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12 (2010), 468–476.
115. Calvet, C.Y., Andre, F.M., Mir, L.M., The culture of cancer cell lines as tumorspheres does not systematically result in cancer stem cell enrichment. PLoS One, 9, 2014, e89644.
116. Ye, Y., Tian, H., Lange, A.R., Yearsley, K., Robertson, F.M., Barsky, S.H., The genesis and unique properties of the lymphovascular tumor embolus are because of calpain-regulated proteolysis of E-cadherin. Oncogene 32 (2013), 1702–1713.
117. Ferrante, A., Rainaldi, G., Indovina, P., Indovina, P.L., Santini, M.T., Increased cell compaction can augment the resistance of HT-29 human colon adenocarcinoma spheroids to ionizing radiation. Int J Oncol 28 (2006), 111–118.
118. Roller, M.R., Owen, S.P., Heidelberger, C., Studies on the organ culture of human tumors. Cancer Res 26 (1966), 626–637.
119. Dipaolo, J.A., Dowd, J.E., Evaluation of inhibition of human tumor tissue by cancer chemotherapeutic drugs with an in vitro test. J Natl Cancer Inst 27 (1961), 807–815.
120. De Witt Hamer, P.C., Van Tilborg, A.A., Eijk, P.P., Sminia, P., Troost, D., Van Noorden, C.J., Ylstra, B., Leenstra, S., The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids. Oncogene 27 (2008), 2091–2096.
121. Dubessy, C., Merlin, J.M., Marchal, C., Guillemin, F., Spheroids in radiobiology and photodynamic therapy. Crit Rev Oncol Hematol 36 (2000), 179–192.
122. Durand, R.E., Sutherland, R.M., Effects of intercellular contact on repair of radiation damage. Exp Cell Res 71 (1972), 75–80.
123. West, C.M., Sutherland, R.M., The radiation response of a human colon adenocarcinoma grown in monolayer, as spheroids, and in nude mice. Radiat Res 112 (1987), 105–115.
124. Chapman, J.D., Dugle, D.L., Reuvers, A.P., Meeker, B.E., Borsa, J., Letter: studies on the radiosensitizing effect of oxygen in Chinese hamster cells. Int J Radiat Biol Relat Stud Phys Chem Med 26 (1974), 383–389.
125. Olive, P.L., Durand, R.E., Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Rev 13 (1994), 121–138.
126. Phillips, T.M., McBride, W.H., Pajonk, F., The response of CD24(−/low)/CD44 + breast cancer-initiating cells to radiation. J Natl Cancer Inst 98 (2006), 1777–1785.
127. Kaaijk, P., Troost, D., Sminia, P., Hulshof, M.C., van der Kracht, A.H., Leenstra, S., Bosch, D.A., Hypofractionated radiation induces a decrease in cell proliferation but no histological damage to organotypic multicellular spheroids of human glioblastomas. Eur J Cancer 33 (1997), 645–651.
128. Desoize, B., Jardillier, J., Multicellular resistance: a paradigm for clinical resistance?. Crit Rev Oncol Hematol 36 (2000), 193–207.
129. Wartenberg, M., Ling, F.C., Muschen, M., Klein, F., Acker, H., Gassmann, M., Petrat, K., Putz, V., Hescheler, J., Sauer, H., Regulation of the multidrug resistance transporter P-glycoprotein in multicellular tumor spheroids by hypoxia-inducible factor (HIF-1) and reactive oxygen species. FASEB J 17 (2003), 503–505.
130. Frankel, A., Buckman, R., Kerbel, R.S., Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Cancer Res 57 (1997), 2388–2393.
131. Laurent, J., Frongia, C., Cazales, M., Mondesert, O., Ducommun, B., Lobjois, V., Multicellular tumor spheroid models to explore cell cycle checkpoints in 3D. BMC Cancer, 13, 2013, 73.
132. Kim, T.H., Mount, C.W., Gombotz, W.R., Pun, S.H., The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles. Biomaterials 31 (2010), 7386–7397.
133. Barbone, D., Yang, T.M., Morgan, J.R., Gaudino, G., Broaddus, V.C., Mammalian target of rapamycin contributes to the acquired apoptotic resistance of human mesothelioma multicellular spheroids. J Biol Chem 283 (2008), 13021–13030.
134. Frankel, A., Man, S., Elliott, P., Adams, J., Kerbel, R.S., Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Clin Cancer Res 6 (2000), 3719–3728.
135. Pickl, M., Ries, C.H., Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumab. Oncogene 28 (2009), 461–468.
136. Chekenya, M., Krakstad, C., Svendsen, A., Netland, I.A., Staalesen, V., Tysnes, B.B., Selheim, F., Wang, J., Sakariassen, P.O., Sandal, T., et al. The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling. Oncogene 27 (2008), 5182–5194.
137. Erler, J.T., Weaver, V.M., Three-dimensional context regulation of metastasis. Clin Exp Metastasis 26 (2009), 35–49.
138. Jessup, J.M., Brown, D., Fitzgerald, W., Ford, R.D., Nachman, A., Goodwin, T.J., Spaulding, G., Induction of carcinoembryonic antigen expression in a three-dimensional culture system. In Vitro Cell Dev Biol Anim 33 (1997), 352–357.
139. Friedl, P., Alexander, S., Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147 (2011), 992–1009.
140. Vinci, M., Box, C., Zimmermann, M., Eccles, S.A., Tumor spheroid-based migration assays for evaluation of therapeutic agents. Methods Mol Biol 986 (2013), 253–266.
141. Sodek, K.L., Ringuette, M.J., Brown, T.J., Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype. Int J Cancer 124 (2009), 2060–2070.
142. Gole, B., Duran Alonso, M.B., Dolenc, V., Lah, T., Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro. Pathol Oncol Res 15 (2009), 711–723.
143. Hauptmann, S., Budianto, D., Denkert, C., Kobel, M., Borsi, L., Siri, A., Adhesion and migration of HRT-18 colorectal carcinoma cells on extracellular matrix components typical for the desmoplastic stroma of colorectal adenocarcinomas. Oncology 65 (2003), 174–181.
144. Bracke, M.E., Van Larebeke, N.A., Vyncke, B.M., Mareel, M.M., Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro. Br J Cancer 63 (1991), 867–872.
145. Gondi, C.S., Lakka, S.S., Yanamandra, N., Siddique, K., Dinh, D.H., Olivero, W.C., Gujrati, M., Rao, J.S., Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis. Oncogene 22 (2003), 5967–5975.
146. Grummer, R., Hohn, H.P., Mareel, M.M., Denker, H.W., Adhesion and invasion of three human choriocarcinoma cell lines into human endometrium in a three-dimensional organ culture system. Placenta 15 (1994), 411–429.
147. Aaberg-Jessen, C., Norregaard, A., Christensen, K., Pedersen, C.B., Andersen, C., Kristensen, B.W., Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures. Int J Clin Exp Pathol 6 (2013), 546–560.
148. Engebraaten, O., Bjerkvig, R., Lund-Johansen, M., Wester, K., Pedersen, P.H., Mork, S., Backlund, E.O., Laerum, O.D., Interaction between human brain tumour biopsies and fetal rat brain tissue in vitro. Acta Neuropathol 81 (1990), 130–140.
149. Burleson, K.M., Boente, M.P., Pambuccian, S.E., Skubitz, A.P., Disaggregation and invasion of ovarian carcinoma ascites spheroids. J Transl Med, 4, 2006, 6.
150. Tomlinson, J.S., Alpaugh, M.L., Barsky, S.H., An intact overexpressed E-cadherin/alpha, beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma. Cancer Res 61 (2001), 5231–5241.
151. Ye, Y., Tellez, J.D., Durazo, M., Belcher, M., Yearsley, K., Barsky, S.H., E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking. Anticancer Res 30 (2010), 3903–3910.
152. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., Kirchner, T., Opinion: migrating cancer stem cells—an integrated concept of malignant tumour progression. Nat Rev Cancer 5 (2005), 744–749.
153. Scheel, C., Weinberg, R.A., Cancer stem cells and epithelial–mesenchymal transition: concepts and molecular links. Semin Cancer Biol 22 (2012), 396–403.
154. Rosen, J.M., Jordan, C.T., The increasing complexity of the cancer stem cell paradigm. Science 324 (2009), 1670–1673.
155. Borovski, T., De Sousa, E.M.F., Vermeulen, L., Medema, J.P., Cancer stem cell niche: the place to be. Cancer Res 71 (2011), 634–639.
156. Ma, Y., Liang, D., Liu, J., Axcrona, K., Kvalheim, G., Giercksky, K.E., Nesland, J.M., Suo, Z., Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines. Tumour Biol 33 (2012), 967–978.
157. Keith, B., Simon, M.C., Hypoxia-inducible factors, stem cells, and cancer. Cell 129 (2007), 465–472.
158. Bao, B., Azmi, A.S., Ali, S., Ahmad, A., Li, Y., Banerjee, S., Kong, D., Sarkar, F.H., The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta 1826 (2012), 272–296.
159. Xiao, Y., Ye, Y., Yearsley, K., Jones, S., Barsky, S.H., The lymphovascular embolus of inflammatory breast cancer expresses a stem cell-like phenotype. Am J Pathol 173 (2008), 561–574.
160. Emmink, B.L., Van Houdt, W.J., Vries, R.G., Hoogwater, F.J., Govaert, K.M., Verheem, A., Nijkamp, M.W., Steller, E.J., Jimenez, C.R., Clevers, H., et al. Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan. Gastroenterology 141 (2011), 269–278.
161. Waleh, N.S., Brody, M.D., Knapp, M.A., Mendonca, H.L., Lord, E.M., Koch, C.J., Laderoute, K.R., Sutherland, R.M., Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker. Cancer Res 55 (1995), 6222–6226.
162. Kunz-Schughart, L.A., Doetsch, J., Mueller-Klieser, W., Groebe, K., Proliferative activity and tumorigenic conversion: impact on cellular metabolism in 3-D culture. Am J Physiol Cell Physiol 278 (2000), C765–C780.
163. Grill, J., Lamfers, M.L., van Beusechem, V.W., Dirven, C.M., Pherai, D.S., Kater, M., Van der Valk, P., Vogels, R., Vandertop, W.P., Pinedo, H.M., et al. The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro. Mol Ther 6 (2002), 609–614.
164. Cheng, G., Tse, J., Jain, R.K., Munn, L.L., Micro-environmental mechanical stress controls tumor spheroid size and morphology by suppressing proliferation and inducing apoptosis in cancer cells. PLoS One, 4, 2009, e4632.
165. Gottfried, E., Kunz-Schughart, L.A., Andreesen, R., Kreutz, M., Brave little world: spheroids as an in vitro model to study tumor–immune-cell interactions. Cell Cycle 5 (2006), 691–695.
166. Gottfried, E., Kunz-Schughart, L.A., Ebner, S., Mueller-Klieser, W., Hoves, S., Andreesen, R., Mackensen, A., Kreutz, M., Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107 (2006), 2013–2021.
167. Owen, M.R., Byrne, H.M., Lewis, C.E., Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites. J Theor Biol 226 (2004), 377–391.
168. Seidl, P., Huettinger, R., Knuechel, R., Kunz-Schughart, L.A., Three-dimensional fibroblast-tumor cell interaction causes downregulation of RACK1 mRNA expression in breast cancer cells in vitro. Int J Cancer 102 (2002), 129–136.
169. Osterholm, C., Lu, N., Liden, A., Karlsen, T.V., Gullberg, D., Reed, R.K., Kusche-Gullberg, M., Fibroblast EXT1-levels influence tumor cell proliferation and migration in composite spheroids. PLoS One, 7, 2012, e41334.
170. Correa de Sampaio, P., Auslaender, D., Krubasik, D., Failla, A.V., Skepper, J.N., Murphy, G., English, W.R., A heterogeneous in vitro three dimensional model of tumour-stroma interactions regulating sprouting angiogenesis. PLoS One, 7, 2012, e30753.
171. Weiswald, L.B., Guinebretiere, J.M., Richon, S., Bellet, D., Saubamea, B., Dangles-Marie, V., In situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopy. BMC Cancer, 10, 2010, 106.
172. Vamvakidou, A.P., Mondrinos, M.J., Petushi, S.P., Garcia, F.U., Lelkes, P.I., Tozeren, A., Heterogeneous breast tumoroids: an in vitro assay for investigating cellular heterogeneity and drug delivery. J Biomol Screen 12 (2007), 13–20.
173. Kunz-Schughart, L.A., Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor. Cell Biol Int 23 (1999), 157–161.
174. Brouty-Boye, D., Mainguene, C., Magnien, V., Israel, L., Beaupain, R., Fibroblast-mediated differentiation in human breast carcinoma cells (MCF-7) grown as nodules in vitro. Int J Cancer 56 (1994), 731–735.
175. Kojima, N., Takeuchi, S., Sakai, Y., Establishment of self-organization system in rapidly formed multicellular heterospheroids. Biomaterials 32 (2011), 6059–6067.
176. Luraghi, P., Reato, G., Cipriano, E., Sassi, F., Orzan, F., Bigatto, V., De Bacco, F., Menietti, E., Han, M., Rideout, W.M. III, et al. MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors. Cancer Res 74 (2014), 1857–1869.
177. De Witt Hamer, P.C., Leenstra, S., Van Noorden, C.J., Zwinderman, A.H., Organotypic glioma spheroids for screening of experimental therapies: how many spheroids and sections are required?. Cytometry A 75 (2009), 528–534.
178. Christensen, K., Aaberg-Jessen, C., Andersen, C., Goplen, D., Bjerkvig, R., Kristensen, B.W., Immunohistochemical expression of stem cell, endothelial cell, and chemosensitivity markers in primary glioma spheroids cultured in serum-containing and serum-free medium. Neurosurgery 66 (2010), 933–947.